Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-523-656"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-523-656"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-523-6872
lpv:speaker	lp:Mário David2
lpv:spokenAs	member; SEDE (2012-01-19--2014-06-30)3 substitute; INTA (2012-01-19--2014-06-30)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Partido Social Democrata (2009-07-14--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the NATO Parliamentary Assembly (2009-09-16--2014-06-30)3 member; AFET (2012-01-19--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 chair; Delegation for relations with the Mashreq countries (2009-09-17--2014-06-30)3 member; Conference of Delegation Chairs (2009-09-17--2014-06-30)3
lpv:translated text	"The globalisation of markets, on the one hand, and the expiry of patents and growing share of the generics market, on the other hand, have resulted in significant changes to the pharmaceutical industry, forcing it to make adjustments, in an already tough environment, in order to retain its competitiveness. Furthermore, global investments and biotechnological research are on the increase and, given the climate of austerity in Europe, the state of R&D in the EU is cause for concern. In the face of new investment patterns and strategies in the areas of biosciences, biotechnology, pharmaceuticals and medical technology begun by third countries, European companies, even those regarded as examples of success such as AstraZeneca, have been forced to adapt their production to deal with the new challenges. For that reason I voted in favour of this report which mobilises EUR 4 325 854 of the EGF for Sweden."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph